IEL vs SICAGEN: Stock Comparison
IEL shows a lower P/E, while SICAGEN INDIA shows a higher dividend yield, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
IEL leads 3; SICAGEN leads 6 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | IEL | SICAGEN |
|---|---|---|
| Sector | Services | — |
| Industry | Diversified Commercial Services | — |
Price
| Metric | IEL | SICAGEN |
|---|---|---|
| Live Price | ₹25.38 | ₹53.53 |
| Day Change | 5.4% | 0% |
| Volume | 22.52 L | 11,253 |
| 52-Week High | ₹21.84 | ₹74.06 |
| 52-Week Low | ₹18.12 | ₹46.55 |
| Distance from 52W High | 16.21% | -27.72% |
Valuation
| Metric | IEL | SICAGEN |
|---|---|---|
| Market Cap | ₹0 Cr | ₹221 Cr |
| P/E Ratio | 0x | 11.41x |
| P/B Ratio | -1.96x | 0.47x |
| EPS | ₹-0.16 | ₹1.75 |
| Book Value | — | ₹125.09 |
| Dividend Yield | 0% | 3.74% |
Growth
| Metric | IEL | SICAGEN |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | -18.84% | 115.12% |
| Qtr Profit Growth | 46.9% | 26.46% |
Profitability & Leverage
| Metric | IEL | SICAGEN |
|---|---|---|
| ROE | — | 3.07% |
| ROCE | -160.9% | 4.15% |
| Net Margin | 0% | 1.86% |
| Operating Margin | -253.12% | 4.48% |
| Debt to Equity | — | 0.13x |
Shareholding
As of Sep 2025 • change vs previous quarter| Metric | IEL | SICAGEN |
|---|---|---|
| Promoter Holding | 36.24% | 23.92% |
| FII Holding | 0.24%▲ 0.17 pp | 2.47% |
| DII Holding | 0% | 0.58% |
| Public Holding | 62.56%▼ 0.17 pp | 35.81% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: IEL and SICAGEN INDIA.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.